In 1991, Dr. Irani graduated in General Medicine from the Faculty of Medical Sciences in Beirut, Lebanon. He also obtained his specialist diploma in General Surgery from the Faculty of Medical Sciences in Beirut in 1996.
Over the past 20 years, Dr. Nabil has developed an expertise in minor surgeries, digestive surgeries, minimally invasive surgeries, laparoscopic colorectal surgeries, breast pathologies and surgeries and varicose veins of the lower limbs.
He is a general surgeon at the Metro Medic clinic in downtown Montreal. He puts his expertise and wealth of medical knowledge to work for his patients.
2020 Blvd Robert-Bourassa, Local 1920
Montréal, Québec
H3A 2A5
Although there are no mandatory vaccinations for children in Canada, the Government of Quebec has set up the Quebec Immunization Program (QIP),
Moles are small skin lesions that can be found anywhere on the body. Many patients wish to have these moles removed for
Obesity, which affects affects 1 billion people worldwide and nearly one in four Canadians, is a complex medical condition that significantly increases
Voir cette publication sur Instagram Une publication partagée par ELNA Médical | Cliniques médicales (@elnamedical) In Canada, major depression affects approximately 5.4%
Voir cette publication sur Instagram Une publication partagée par ELNA Médical | Cliniques médicales (@elnamedical) In the healthcare field, the choice of
Cervical cancer is a disease mainly caused by human papillomaviruses (HPV), which can be easily detected with an HPV test or Pap
ELNA has acquired the Brunswick Health Group, a pillar of Quebec’s healthcare infrastructure for close to 30 years.
Voir cette publication sur Instagram Une publication partagée par ELNA Médical | Cliniques médicales (@elnamedical) Also known as the influenza virus, the
ELNA continues its strategic growth with the acquisition of the largest medical group in the greater Quebec City area comprised of both La Cité Médicale in Sainte-Foy and La Cité Médicale in Charlesbourg.
A new agreement has been signed between OPTITHERA, ELNA Medical Group, and Génome Québec as part of Genome Canada’s Genomic Applications Partnership Program (GAPP).
